The purpose of the current study was to examine IGFBP-3, -4, and -5 mRNA and protein expression levels as a function of muscle type, age, and regrowth from an immobilization-induced atrophy in Fischer 344 x Brown Norway rats. IGFBP-3 mRNA expression in the 4-mo-old animals was significantly higher in the red and white portions of the gastrocnemius muscle compared to the soleus muscle. However, there was no significant differences in IGFBP-3 mRNA expression between any of the muscle groups in the 30-mo-old animals. There were no significant differences in IGFBP-5 mRNA expression in any of the muscle groups, while in the 30-mo-old animals there was significantly less IGFBP-5 mRNA expression in the white gastrocnemius compared to the red gastrocnemius muscles. While IGFBP-3 and -5 proteins were detected in the type I soleus muscle with Western blot analyses, no detection was observed in the type II red and white portions of the gastrocnemius muscle. Aging from adult (18 mo) to old (30 mo) was associated with decreases in IGFBP-3 mRNA and protein and -5 protein only in the soleus muscle. After 10 days of recovery from 10 days of hindlimb immobilization, IGFBP-3 mRNA and protein increased in soleus muscles from young (4-mos), however only IGFBP-3 protein increased in the old (30-mos) rats. While there were no changes in IGFBP-5 mRNA expression during recovery, IGFBP-5 protein in the 10-day recovery soleus muscle did increase in the young, but not in old rats. As the functions of IGFBPs are to modulate IGF-I action on muscle size and phenotype, it is hypothesized that IGFBP-3 and -5 proteins may have potential modulatory roles in type I fiber dominated muscles, aging, and regrowth from atrophy.
Skeletal muscle is a plastic tissue that retains an intrinsic ability to alter its structural and functional properties to a given environment (12) . For example, skeletal muscle atrophies under conditions of immobilization or unweighting (10, 34) , however when muscle in young animals (2-6 mo) is reloaded the muscle retains the ability to recover its previously lost mass (11) . Recently, others and we have found that muscle in aged animals does not retain the ability to recover lost muscle mass from immobilization (14) or hypertrophy during functional overload (9) . The inability for skeletal muscle in aged animals to regrow or hypertrophy suggests that either positive stimulators of muscle growth are 'missing' or negative regulators of muscle hypertrophy are highly active.
Currently, there is little evidence examining what different possible factors could contribute to the inability of the aged skeletal muscle to adapt to increases in skeletal muscle load.
When skeletal muscle is challenged with an increased mechanical load, there are rapid increases in autocrine/paracrine growth factors that activate signaling mechanisms that promote skeletal muscle hypertrophy (3, 29) . One such growth factor system is insulin-like growth factor-I (IGF-I), which plays an essential role in the formation and maintenance of skeletal muscle (19) . Mice lacking the IGF-I receptor exhibit marked muscle hypoplasia and die soon after birth because of respiratory failure (24) , and mice with a dominant negative IGF-I receptor have smaller skeletal muscles (19) . In contrast, mice overexpressing IGF-I exhibit skeletal muscle hypertrophy (16, 27) . In addition, rats infused with exogenous IGF-I specifically on the skeletal muscle exhibit muscle hypertrophy (4) , and the exogenous IGF-I also rescues skeletal muscle from sarcopenia (14) .
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Endogenous IGF-I likely participates in the regulation of numerous myogenic components during overload-induced hypertrophy in mature mammalian skeletal muscle (17) . Overloading of skeletal muscle produces hypertrophy and is associated with increases in IGF-I mRNA and peptide level (1) . In addition, increased IGF-I expression within skeletal muscle fibers after resistance exercise has been found with immunohistochemical procedures in rats (35) and humans (32) . On the other hand, unloading of skeletal muscle is associated with a lowering of IGF-I mRNA (6) .
Furthermore, skeletal muscle IGF-I mRNA expression was only decreased during maturation, but not with aging (21) . Therefore, based on the above evidence, it is likely that IGF-I plays a significant role in the skeletal muscle growth process.
IGF-binding proteins (IGFBPs) are multifunctional proteins that transport IGFs in
circulation, localize IGFs in specific cell types, and alter binding characteristics of IGFs to receptors (23) . Six different IGFBP proteins have been cloned and sequenced (33) .
Initially, IGFBPs were thought to function as proteins that extended the half-life of IGFs in the circulation and also inhibited the binding of IGF to a specific receptor (33) . The prevention of IGF-I from binding a receptor was thought to be essential since IGF-I can interact with the insulin receptor and IGF-I concentrations in the serum are 1000 times higher than insulin (30) . Now it is known that IGFBPs can localize in the extracellular matrix, modulate IGFs interaction with a receptor and/or act as a localize storage depot for IGFs (33) . Thus, IGFBPs likely modulate IGF-I's effectiveness and exert IGF-Iindependent effects on various tissues. Although, the interactions of IGFBPs and IGF-I have been investigated very carefully, very little information is known about the changes in IGFBP protein expression in skeletal muscle during changes in loading patterns of the E253-2002.R1 Final accepted version 5 animals. Currently, there is less information available on whether IGFBP protein expression might be altered in old animals with aged-induced muscle atrophy. Therefore, the purposes of the current report were to determine protein levels of IGFBP-3, -4, and -5 in slow and fast muscles and their response to increased loading of these muscles in young and old rats. The hypotheses of this study were that IGFBP-3, -4, and -5 protein concentrations would be the same in type I and II muscles, would be altered with aging, and would fail to respond during reloading of old muscles recovering from atrophy.
Methods
Materials. IGFBP-3, IGFBP-4 and IGFBP-5 antibodies were purchased from GroPep (Adelaide BC, Australia). All remaining chemicals were purchased from Sigma Chemical (St. Louis, MO) or Fisher Scientific.
Animals. All animals were maintained in animal care facilities and kept on a 12:12 light-dark cycle and given rat chow and water ad libitum. Young (4-mo), adult (18-mo) and old (30-mo) male, F1 generation Fischer 344 x Brown Norway rats were obtained from NIA (Harlan, Indianapolis).
Hindlimb Immobilization. The hindlimb immobilization of the rats was preformed according to the previously described procedures of Booth (11) . Rats were lightly anesthetized with an intraperitoneal injection of ketamine (50mg/kg body wt) and acepromazine (5mg/kg body wt) for attachment of the casting material. The hindlimbs of the animals were fixed in plantar flexion so that calf muscle is in a shortened position as described previously (11) . The animals were then checked daily for damage to casting material, which was subsequently repaired as necessary. After ten days, the casting material was removed from anesthetized rats and the animals were returned to their E253-2002.R1 Final accepted version 6 cages. The animals were allowed to recover for 10 days and were then sacrificed. The muscles were removed and processed (see below). The rationale for the use of this model had the multiple reasons. By utilizing a model of hindlimb immobilization, significant amounts of atrophy can be produced in both type I-and II-predominant muscles (~30-40% decrease in muscle wet weight and muscle protein content) and with the subsequent removal of the casting material, a reloaded muscle is induced to regrow through normal ambulation of the animal (11) . In addition, after 30 days of recovery, whereas muscle in young animals regrows from limb immobilization (11) , muscle in old animals does not regrow (14) . Finally, we believe that this model mimics the response that would be exhibited by a human who is forced into extended periods of bed rest and then required to assume normal ambulation.
Muscle Collection and preparation. At the specified time points the animals were anesthetized (75 mg/kg ketamine, 3 mg/kg xylazine, and 5 mg/kg acepromazine), and the muscle was removed from the animals, weighed, then immediately frozen in liquid nitrogen, and finally stored at -80°C until further analysis. The muscle was later homogenized as 5% (wt/vol.) in buffer containing 50 mM HEPES (pH 7.4), 0.1% Triton X-100, 4 mM EGTA, 10 mM EDTA, 15 Na 4 P 2 O 7 •10H 2 O, 100 mM β-glycerophosphate, 25 mM NaF, 5 mM Na 3 VO 4 , 50 µg/ml leupeptin, 50 µg/ml pepstatin, and 33 µg/ml aprotinin. All homogenizations were performed on ice with a ground glass homogenizer using a variable speed motor. The homogenate was then centrifuged at 13,000 rpm for 10 min. Protein concentrations were determined on all samples through the Bradford protein assay (Bio-Rad, CA).
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Western Blotting. Equal amounts of total protein were then resolved on SDS-PAGE gels and subsequently transferred to nitrocellulose membranes as previously described (13) . All blots were then incubated with Ponceau S (Sigma, MO) to ensure equal loading (data not shown). The membranes were then blocked with 5% bovine serum albumin (BSA) in Tris-buffer saline with 0.1% Tween (TBS-T) and 1mM sodium orthovanadate. All membranes were then probed with the appropriate antibody overnight, which was diluted in 5% BSA-TBS. The antibodies were used at the RNA extraction. Total RNA was extracted from pre-weighed frozen muscles samples using TRIzol reagent (Invitrogen, CA) based on previously described techniques (15) . RNA concentrations were determined by measuring the optical density at 260 nm. The quality of the RNA was examined visually by ethidium bromide staining of 18S and 28S under ultraviolet light. The samples were subsequently stored at -80° C for subsequent analysis.
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Reverse transcription. Two micrograms of total RNA were reversed transcribed for each sample using the SuperScript II RT (Invitrogen, CA), mixed oligo(dT) (Invitrogen, CA) and random decamers (500 µg/mL) (Ambion, TX) in a 20 µL reaction volume at 42° C for 50 minutes. The reaction was inactivated by incubation at 70° C for 15 minutes. The samples were subsequently stored at 4° C for later analyses.
Polymerase Chain Reaction. All methods were adapted according to the previously described methods (2) . A semi-quantitative RT-PCR was employed using 18S For all PCR reactions the specific target and 18S were co-amplified, therefore allowing the 18S signal to serve as an internal control and to further allow for differences in the total amount of RNA in each sample. The 18S primers were mixed with specific competimers (Ambion, TX) at ratio of 2:8 for all three IGFBP targets. Inclusion of the 18S competimers were necessary to ensure that the 18S signal was linearly amplified with the specific IGFBP target. For each primer set, the experimental conditions were The PCR products were then separated on a 2-3% agarose gel and stained with SYBR Gold Nucleic Acid Gel Stain (Molecular Probes, OR). The gels were scanned and signal quantification was performed with ImageQuant (Molecular Dynamics, CA) software.
The signal determined for each target was subsequently normalized to the signal for the 18S target.
Statistics. All data were expressed as means ± SEM. Statistical significance was determined using a one-way analysis of variance for multiple comparisons followed by a Tukey's post hoc test. A P value of less than 0.05 was considered significant.
Results

Body and muscle mass of 4-mo-, 18-mo-, and 30-mo-old animals.
There was a significant 40% and 48% increase in the body mass of the 18-and 30-mo-old animals compared to the 4-month-old animals, respectively, in the aging study (Table 1) .
However, there was no significant difference in body mass between the 18-mo and 30-mo-old animals. In addition, there were no differences in absolute soleus muscle mass between any of the age groups, but there were significant reductions in the absolute gastrocnemius mass in the 30-mo-old animals by 17 % compared to the 4-mo and 18-moold animals. However, the normalized soleus and gastrocnemius muscle masses were significantly less by 20 and 28% and by 28 and 44% in 18-mo and 30-mo-old animals compared to the 4-mo-old animals, respectively (Table 1) . Only the normalized gastrocnemius muscle mass was significantly different between the 18-mo and 30-mo-old animals.
In the recovery study, the body, absolute soleus, and normalized soleus muscle masses from the 4-mo-old recovery animals were significantly less than the 4-mo-old control group by 15%, 32% and 20%, respectively ( Table 1 ). The body, absolute soleus, and normalized soleus masses from the 30-mo-old recovery animals were significantly less than the 30-mo-old control group by 19%, 31%, and 16%, respectively (Table 1) .
Muscles composed of distinct fiber types express varying levels of IGFBP-3, IGFBP-4 and IGFBP-5 mRNA and protein in 4-mo-, 18-mo-and 30-mo-old animals.
IGFBP-3 mRNA expression was significantly higher by ~50% in the red and white gastrocnemius muscle compared to the soleus muscle in the 4-mo-old animals ( Fig.   1A ), however there were no significant differences in IGFBP-3 mRNA expression between any of the different muscle types in the 30-mo-old animals ( Fig 1D) .
Using an antibody specific for IGFBP-4, we were unable to detect IGFBP-4 expression at the protein level in skeletal muscle in any muscle or condition measured (data not shown). IGFBP-4 mRNA expression was significantly lower in the red (~58%) and white gastrocnemius (~82%) muscles compared to the soleus muscle in the 4-mo-old animals (data not shown). There was no significant differences in IGFBP-4 mRNA expression between any of the muscle groups in the 30-mo-old animals (data not shown).
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IGFBP-5 mRNA expression does not differ between the soleus, red or white gastrocnemius in the 4-mo-old animals ( Fig. 2A) . However, in the 30-mo-old animals there was a significantly less IGFBP-5 mRNA (~30%) expression in the white gastrocnemius compared to the red gastrocnemius (Fig. 2D) , while there was no significant difference between the soleus and white gastrocnemius muscles (p = 0.13).
IGFBP-3 (Fig. 1B, C, E) and IGFBP-5 (Fig. 2B, C, E) protein expression levels were mainly restricted to the soleus muscle in all age groups. In addition, IGFBP-3 (Fig.   1B , C, E) and IGFBP-5 (Fig. 2B , C, E) protein expression levels were nearly undetectable in the red and white portions of the gastrocnemius muscle. Therefore, aging comparisons were restricted to the soleus muscles.
Age levels of IGFBP-3 and IGFBP-5 mRNA and protein in the soleus muscle.
IGFBP-3 mRNA expression was significantly higher in the soleus muscles from the 18-mo-old animals by 90% and 104% compared to the 4-mo and 30-mo old animals, respectively. However, there was no difference in IGFBP-3 mRNA expression in the soleus muscle between the 4-mo and 30-mo animals (Fig. 3A) .
IGFBP-3 protein expression was significantly increased by 95% in soleus muscle taken from 18-mo-old compared to soleus muscles taken from 4-mo and 30-mo-old rats (Fig. 3B) . There was no significant difference in IGFBP-3 protein expression in the soleus muscle between 4-mo-and 30-mo-old rats.
There was no statistical differences in IGFBP-4 mRNA expression in the soleus muscles isolated from any age group (data not shown as its protein was not detectable).
IGFBP-5 mRNA expression was significantly higher by 70% in the soleus muscle isolated from the 18-mo-old animals compared to the soleus from the 4-mo-old animals Fig. 4A) , while there were no significant differences in IGFBP-5 mRNA expression in the soleus muscle isolated from the 4-mo and 30-mo old animals (p = 0.069) IGFBP-5 protein expression was significantly reduced by 60% in the soleus muscle taken from 30-mo-old animals compared to soleus muscles taken from 4-mo-and 18-mo-old animals (Fig. 4B) . No significant differences were detected in IGFBP-5 protein expression between the 4-mo-and 18-mo-old animals. IGFBP-3 mRNA significantly increased after 10 days of recovery from a 10-d bout of immobilization by 49% in the soleus isolated from 4-mo-old animals (Fig. 5A ).
However, there was no change (p=0.16) detected in IGFBP-3 mRNA expression after 10 days of recovery in the 30-mo-old animals in the soleus muscle (Fig. 5C ).
IGFBP-3 protein expression was significantly elevated by 43% and 56% in both the 4-mo-and 30-mo-old 10-day regrowth animals compared to the age-matched control animals ( Fig. 5B and 5D ).
IGFBP-4 mRNA expression significantly decreased at 10 days of recovery in the soleus muscle of the 4-mo-old animals (data not shown), but there was no change after 10 days of recovery in the 30-mo-old animals (data not shown as its protein was not detectable).
IGFBP-5 mRNA expression did not change after 10 days of recovery in the soleus muscle of the 4-mo (Fig. 6A) or the 30-mo-old ( (Fig 6B) . However, there was no change in IGFBP-5 protein expression in regrowing 30-mo-old soleus muscle compared to its age-matched control (Fig 6D) .
Discussion
While IGFBP-3 and -5 proteins were found in the type I muscle fiber-dominated (soleus) muscle, their absence, at least at the sensitivity of Western analysis, in type IIb-(white gastrocnemius) muscle fiber-dominated muscles was unexpected since two papers have reported the existence of mRNAs for IGFBP-3 and -5 in type II muscles (5, 7), whose mRNA presence in type II muscles was verified in the current study ( Figs. 1 & 2) .
The rat soleus muscle is composed of 86% type I muscle fibers, while the red and white portions of the gastrocnemius muscles of 5-mo-old rats had ~20% type I myosin heavy chain expression (20) to no type I muscle fibers, respectively (18) . Thus, a novel suggestion of the aforementioned observations may be that important translational and post-translational mechanisms exist for the regulation of IGFBP-3, -4 and -5 expressions in type II fiber-dominated rat muscle (Table 2) .
Previous work on the expression of IGFBP proteins in skeletal muscle fiber types had been restricted to tissue culture. Conditioned media containing rabbit adult myoblasts obtained from type I muscle exhibited the presence of a 30-31 kDa band with ligand blotting that was interpreted by Barjot et al. (7) to correspond to IGFBP-5.
However, IGFBP-5 protein was not detected in the conditioned media from adult myoblasts isolated from a rabbit muscle consisting of nearly 100% type II fibers (7).
The current observed association (Fig 3) for a differential expression of IGFBP-5 proteins between types I and IIb muscles extends the aforementioned developmental relationship, and allows formulation of a hypothesis that IGFBP-5 either has a causal effect on fiber type phenotype, or is a secondary consequence of muscle phenotype. The role of IGFBP-5 in the modulation of IGF system between types I and II muscles in mature and aged animals remains to be defined.
Barjot et al. (7) found no differences in the amount of IGFBP-3 protein secreted into the media between types I and II myoblasts. In contrast, whereas IGFBP-3 protein was found in the type I soleus muscle, it was undetectable with Western analysis in whole muscle homogenates of the red and white gastrocnemius ( (27) . Therefore, since several studies have reported fiber type shifts due to excess IGF-I, it is possible to suggest that high levels of IGFBP-3 and -5 protein expression in slow fibers could attenuate and/or prevent IGF-I from modulating the fiber type expression in the soleus muscle. However, this suggestion remains to be tested.
Previous publications have indicated that IGFBP mRNA transcript concentrations differ among muscle types (6, 8) . For example, IGFBP-5 mRNA levels are lower in the soleus muscle (predominantly type I fibers) compared to the gastrocnemius and tibalis anterior muscles (predominantly type II fibers) of 200-gram male Wistar rats (8) . Yet, in the current study IGFBP-5 mRNA showed no difference muscle type specificity in the young animals, while the IGFBP-5 protein shows the opposite fiber type predominance by being higher in the soleus muscle of 4-mo-old rats ( Fig. 2; Table 2 ). In addition, the current study found that IGFBP-3 mRNA expression is higher in the red and white portions of the gastrocnemius muscles compared to the soleus muscle of 4-mo-old rats. Table 2 ).
This suggests that a post-transcriptional mechanism may be regulating the increase in IGFBP-5 protein expression in the soleus muscle with increased load. Intriguingly, the hypothesized post-transcriptional mechanism might be dysfunctional in the 30-mo-old rats in that there was no increase in IGFBP-5 protein expression with increased load. The results of the current study demonstrate that IGFBP-3 and -5 protein expressions in skeletal muscles differ between types I and II fiber-dominated muscles, maturation and aging, and young and old rats during regrowth from limb immobilization.
Through the examination of our data and that published by other groups, it is appears that Experimental groups were: 4-mo-old control animals (n=5), 4-mo-old regrowing animals (n=5-9), 30-mo-old control animals (n=5), and 30-mo-old regrowing animals (n=5-8).
Representative gels and blots are depicted below the figures. * Indicates statistically different than control animals at p<0.05 level. 
Regrowth from atrophy ↑(4mo)/↔(30mo) (Fig. 6 )
Overload hypertrophy ↑ ( 
